Found: 12
Select item for more details and to access through your institution.
CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 6, p. 1091, doi. 10.1007/s10147-016-1017-6
- By:
- Publication type:
- Article
Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 6, p. 1147, doi. 10.1007/s10147-015-0841-4
- By:
- Publication type:
- Article
Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 4, p. 670, doi. 10.1007/s10147-012-0422-8
- By:
- Publication type:
- Article
Development and validation of the Japanese version of the Decisional Conflict Scale to investigate the value of pharmacists' information: a before and after study.
- Published in:
- BMC Medical Informatics & Decision Making, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1472-6947-13-50
- By:
- Publication type:
- Article
Development and validation of the Japanese version of the Decisional Conflict Scale to investigate the value of pharmacists' information: a before and after study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin-or irinotecan-based treatment.
- Published in:
- Molecular & Clinical Oncology, 2014, v. 2, n. 3, p. 356, doi. 10.3892/mco.2014.254
- By:
- Publication type:
- Article
Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer.
- Published in:
- BMC Palliative Care, 2013, v. 12, n. 1, p. 38, doi. 10.1186/1472-684X-12-38
- By:
- Publication type:
- Article
Functional Complementation Assay for 47 MUTYH Variants in a MutY-Disrupted Escherichia Coli Strain.
- Published in:
- Human Mutation, 2015, v. 36, n. 7, p. 704, doi. 10.1002/humu.22794
- By:
- Publication type:
- Article
Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801).
- Published in:
- Oncology, 2014, v. 87, n. 1, p. 7, doi. 10.1159/000360989
- By:
- Publication type:
- Article
Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial.
- Published in:
- Acute Medicine & Surgery, 2018, v. 5, n. 4, p. 362, doi. 10.1002/ams2.368
- By:
- Publication type:
- Article
A survey on infection control in emergency departments in Japan.
- Published in:
- Acute Medicine & Surgery, 2018, v. 5, n. 4, p. 374, doi. 10.1002/ams2.360
- By:
- Publication type:
- Article